首页 > 最新文献

DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)最新文献

英文 中文
A 28-Year-Old Male Patient With Right Heart Failure Due To Pulmonary Hypertension 一例28岁男性肺动脉高压右心衰患者
Pub Date : 2022-11-01 DOI: 10.14710/dmj.v11i6.35882
Yuri Savitri, Wina Yunida M Siregar, Viola Septina, M. F. Arif, Arini Nashirah, Narisha Amelia Putri
Abstract Right Heart Failure (RHF) as a rapidly progressive syndrome with systemic congestion in the setting of impaired RV filling and/or decreased RV outflow output. A 28-year-old male patient, a photographer, lived in North Aceh was admitted to the ED of Cut Meutia Hospital. He was admitted with worsening dyspnea since 2 days before, initiated after a periode of fever. He also complained of fatigue, palpitations in ordinary activities and chest pain occasionally. He had history of presyncope and syncope. He denied any history of hypertension, type 2 diabetes, allergies, and active smoking. He had no congenital or family history of heart disease. Physical examination revealed full of conciousness with slightly abnormal vital sign. He had malar rash, dilated jugular vein. The apex of the heart shifts to the axilla anterior line, S1>S2 with systolic murmur (+). ECG showed complete RBBB with RAD and chest x-ray showed cardiomegaly. The transthoracic echocardiogram revealed severe TR (Tricuspid Regurgitation), dilatation of RARV (Right Atrium Right Ventricle), with severe PH (Pulmonary Hypertension). The patient was diagnosed with RHF (Right Heart Failure) caused by primary PH. The patient was placed on intravenous furosemide, spironolacton, digoxin, and sildenafil. Treatment and lifestyle modification were expected to improve the quality of life.
右心衰(RHF)是一种快速进行性综合征,在右心室充盈受损和/或右心室流出量减少的情况下伴有全身充血。一名28岁的男病人,一名摄影师,住在北亚齐省,被送往Cut Meutia医院的急诊科。他入院前2天呼吸困难加重,开始于一段时间的发烧。他还抱怨疲劳,平时活动时心悸,偶尔胸痛。他有晕厥前期和晕厥病史。他否认有高血压、2型糖尿病、过敏史和吸烟史。他没有先天性心脏病或家族史。体格检查显示意识饱满,生命体征轻微异常。他有颧红疹,颈静脉扩张。心尖移至腋窝前方,S1>S2伴收缩期杂音(+)。心电图显示完整的RBBB伴RAD,胸片显示心脏肿大。经胸超声心动图显示严重的TR(三尖瓣反流),RARV(右心房右心室)扩张,伴严重的PH(肺动脉高压)。患者被诊断为原发性ph引起的右心衰(RHF)。患者给予静脉滴注速尿、旋妥内酯、地高辛和西地那非。治疗和生活方式的改变有望改善生活质量。
{"title":"A 28-Year-Old Male Patient With Right Heart Failure Due To Pulmonary Hypertension","authors":"Yuri Savitri, Wina Yunida M Siregar, Viola Septina, M. F. Arif, Arini Nashirah, Narisha Amelia Putri","doi":"10.14710/dmj.v11i6.35882","DOIUrl":"https://doi.org/10.14710/dmj.v11i6.35882","url":null,"abstract":"Abstract Right Heart Failure (RHF) as a rapidly progressive syndrome with systemic congestion in the setting of impaired RV filling and/or decreased RV outflow output. A 28-year-old male patient, a photographer, lived in North Aceh was admitted to the ED of Cut Meutia Hospital. He was admitted with worsening dyspnea since 2 days before, initiated after a periode of fever. He also complained of fatigue, palpitations in ordinary activities and chest pain occasionally. He had history of presyncope and syncope. He denied any history of hypertension, type 2 diabetes, allergies, and active smoking. He had no congenital or family history of heart disease. Physical examination revealed full of conciousness with slightly abnormal vital sign. He had malar rash, dilated jugular vein. The apex of the heart shifts to the axilla anterior line, S1>S2 with systolic murmur (+). ECG showed complete RBBB with RAD and chest x-ray showed cardiomegaly. The transthoracic echocardiogram revealed severe TR (Tricuspid Regurgitation), dilatation of RARV (Right Atrium Right Ventricle), with severe PH (Pulmonary Hypertension). The patient was diagnosed with RHF (Right Heart Failure) caused by primary PH. The patient was placed on intravenous furosemide, spironolacton, digoxin, and sildenafil. Treatment and lifestyle modification were expected to improve the quality of life.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124832954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric Analysis of Publication on Protein Nanoparticle Using VOSviewer 利用VOSviewer对蛋白质纳米颗粒发表文献计量学分析
Pub Date : 2022-11-01 DOI: 10.14710/dmj.v11i6.35942
R. Ananda, Asep Bayu Dani Nandiyanto
Background: A Study to determine the development of research can be done by bibliometric analysis technique. There are many studies that have been carried out on bibliometric analysis. However, research on bibliometric analysis of published data in the field of protein nanoparticles that has been carried out specifically to determine research development has not been carried out. Objective: This study aims to examine the development of protein nanoparticle research through a bibliometric approach. Methods: The article data was obtained from the Google Scholar database using the publish or perish reference manager software. The keyword "Protein Nanoparticles" is used with a publication time span from 2012 to 2022. Data processing uses Microsoft Excel. Computational mapping using VOSviewer. Results: The article data obtained and considered relevant were 390 articles. The results of the analysis of the development of protein nanoparticle publications in the last 10 years show quite frequent fluctuations. Research fluctuations occurred in 2012 to 2020. There was a decline in 2020-2022 from 35 in 2020 to 19 in 2022. In 2012 and 2014 research on protein nanoparticles became popular, with 47 studies each. Conclusion: Based on the results of mapping the collected article data, it can be seen that the keyword protein nanoparticles is still rarely used in research. It can be concluded that the field of protein nanoparticles is still very likely to be researched and associated with other terms, this will have a higher impact on the novelty of the research.
背景:通过文献计量分析技术来确定研究的发展方向。文献计量学分析已经开展了许多研究。然而,对蛋白质纳米颗粒领域发表的数据进行文献计量分析的研究尚未开展,该研究专门用于确定研究进展。目的:本研究旨在通过文献计量学的方法来考察蛋白质纳米颗粒的研究进展。方法:采用发表或消亡参考文献管理软件从Google Scholar数据库中获取文章数据。关键词“蛋白质纳米颗粒”与出版时间跨度为2012年至2022年。数据处理使用Microsoft Excel。使用VOSviewer计算映射。结果:获得并认为相关的文献资料390篇。对近10年来蛋白质纳米粒子研究进展的分析结果显示出相当频繁的波动。研究波动发生在2012年至2020年。2020-2022年,从2020年的35个下降到2022年的19个。2012年和2014年,对蛋白质纳米颗粒的研究开始流行,各有47项研究。结论:根据收集到的文章数据的制图结果可以看出,关键词蛋白质纳米颗粒在研究中仍然很少使用。由此可以得出结论,蛋白质纳米颗粒领域仍极有可能被研究并与其他术语相关联,这将对研究的新颖性产生较高的影响。
{"title":"Bibliometric Analysis of Publication on Protein Nanoparticle Using VOSviewer","authors":"R. Ananda, Asep Bayu Dani Nandiyanto","doi":"10.14710/dmj.v11i6.35942","DOIUrl":"https://doi.org/10.14710/dmj.v11i6.35942","url":null,"abstract":"Background: A Study to determine the development of research can be done by bibliometric analysis technique. There are many studies that have been carried out on bibliometric analysis. However, research on bibliometric analysis of published data in the field of protein nanoparticles that has been carried out specifically to determine research development has not been carried out. \u0000Objective: This study aims to examine the development of protein nanoparticle research through a bibliometric approach. \u0000Methods: The article data was obtained from the Google Scholar database using the publish or perish reference manager software. The keyword \"Protein Nanoparticles\" is used with a publication time span from 2012 to 2022. Data processing uses Microsoft Excel. Computational mapping using VOSviewer. \u0000Results: The article data obtained and considered relevant were 390 articles. The results of the analysis of the development of protein nanoparticle publications in the last 10 years show quite frequent fluctuations. Research fluctuations occurred in 2012 to 2020. There was a decline in 2020-2022 from 35 in 2020 to 19 in 2022. In 2012 and 2014 research on protein nanoparticles became popular, with 47 studies each. \u0000Conclusion: Based on the results of mapping the collected article data, it can be seen that the keyword protein nanoparticles is still rarely used in research. It can be concluded that the field of protein nanoparticles is still very likely to be researched and associated with other terms, this will have a higher impact on the novelty of the research.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132259473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient With RHD Ec MR Severe, MS Moderate And Trombus In LV, When We Do The Surgeom In Cut Meutia Regional General Hospital 在切梅蒂亚地区总医院行RHD Ec重症、中度、左室畸形患者的手术分析
Pub Date : 2022-11-01 DOI: 10.14710/dmj.v11i6.35993
Yuri Savitri, Helma Humairah, Jauza Raudhatul Jannah Mendrofa, N. Afni, Della Vega Nisha Ayuna
Rheumatic heart disease (RHD) is damage of the heart valves due to acute rheumatic fever (ARF) which results from the body’s autoimmune response to Streptococcus pyogenes (group A Streptococcus bacteria) infection which is a throat infection. Acute rheumatic fever is one of the most important causes of cardiovascular morbidity and mortality in the developing countries. A 25-years-old male patient, domiciled in Alue Dalam, Darul Aman, East Aceh, admitted to emergency department of Cut Mutia hospital, the patient was brought to the hospital by his family at 05.0o pm on January 27th, 2022. Patient referred from Graha Bunda hospital. Patient was admitted to the hospital with complaints shortness of breath. Shortness of breath is felt during activity and worsens at night. Shortness of breath since yesterday. The patient also complained of pounding. The pounding has been felt for five days before arriving at the hospital. The patient also has chest pain, and tired easily. Past medical history such hypertension and diabetes mellitus are denied. Physical examination before treatment was obtained: the patient looked restless, weakness, and akker. Echocardiography examination showed the MR Severe, MS moderate, AR moderate, TR moderate, PH mild, AML calsification, all chamber dilatation, and thrombus LV. The patient was given initial treatment in Cut Mutia General Hospital.
风湿性心脏病(RHD)是由急性风湿热(ARF)引起的心脏瓣膜损伤,这是由身体对化脓性链球菌(A组链球菌)感染(一种喉咙感染)的自身免疫反应引起的。急性风湿热是发展中国家心血管疾病发病和死亡的最重要原因之一。一名25岁男性患者,居住在东亚齐省Darul Aman的Alue Dalam,于2022年1月27日下午5点由其家人带到医院急诊科。格拉哈·本达医院转来的病人。病人因主诉呼吸短促而住进医院。活动时感到呼吸急促,夜间加重。从昨天开始呼吸急促。病人还抱怨有重击感。在到达医院之前,这种重击感已经持续了五天。病人还有胸痛,而且容易疲倦。否认既往病史,如高血压和糖尿病。治疗前进行体格检查:患者看起来坐立不安、虚弱、虚弱。超声心动图检查示MR Severe, MS moderate, AR moderate, TR moderate, PH mild, AML分级,全室扩张,血栓LV。患者在切穆提亚总医院接受初步治疗。
{"title":"Patient With RHD Ec MR Severe, MS Moderate And Trombus In LV, When We Do The Surgeom In Cut Meutia Regional General Hospital","authors":"Yuri Savitri, Helma Humairah, Jauza Raudhatul Jannah Mendrofa, N. Afni, Della Vega Nisha Ayuna","doi":"10.14710/dmj.v11i6.35993","DOIUrl":"https://doi.org/10.14710/dmj.v11i6.35993","url":null,"abstract":"Rheumatic heart disease (RHD) is damage of the heart valves due to acute rheumatic fever (ARF) which results from the body’s autoimmune response to Streptococcus pyogenes (group A Streptococcus bacteria) infection which is a throat infection. Acute rheumatic fever is one of the most important causes of cardiovascular morbidity and mortality in the developing countries. A 25-years-old male patient, domiciled in Alue Dalam, Darul Aman, East Aceh, admitted to emergency department of Cut Mutia hospital, the patient was brought to the hospital by his family at 05.0o pm on January 27th, 2022. Patient referred from Graha Bunda hospital. Patient was admitted to the hospital with complaints shortness of breath. Shortness of breath is felt during activity and worsens at night. Shortness of breath since yesterday. The patient also complained of pounding. The pounding has been felt for five days before arriving at the hospital. The patient also has chest pain, and tired easily. Past medical history such hypertension and diabetes mellitus are denied. Physical examination before treatment was obtained: the patient looked restless, weakness, and akker. Echocardiography examination showed the MR Severe, MS moderate, AR moderate, TR moderate, PH mild, AML calsification, all chamber dilatation, and thrombus LV. The patient was given initial treatment in Cut Mutia General Hospital.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125379359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 52-Years Old Male Patient With Aorta Regurgitation Et Causa Rheumatic Heart Desease In Cut Meutia Regional General Hospital Cut metia地区总医院52岁男性主动脉反流所致风湿性心脏病患者1例
Pub Date : 2022-11-01 DOI: 10.14710/dmj.v11i6.35990
Yuri Savitri, Jauza Raudhatul Jannah Mendrofa
Rheumatic heart disease (rheumatic heart disease) is an acquired heart disease which is a heart valve disorder that persists due to previous acute rheumatic fever, mainly affecting the mitral valve (75%), the aorta (25%), rarely affecting the tricuspid valve, and never affecting the valves lungs. A 52-year-old male patient, domiciled in Mutiara (Alue Awe) Lhokseumawe City, Indonesia. Come for outpatient treatment at Polyclinic of Cut Meutia Hospital. Patients are who routinely go to the polyclinic every month to take medicine. The patient complains of left chest pain, shortness of breath, heart palpitations, cough, tired easily during activities, especially during strenuous activities. History of Diabetes Mellitus is denied, history of hypertension (+). The patient admitted that he was diagnosed with rheumatic heart disease at the age of 19 years. The patient has been undergoing treatment for 33 years by routinely complete checks related to his heart every year and regularly taking medication at the polyclinic every month. The patient admitted at junior high school age he often experienced attacks of fever that went up and down accompanied by pain in the throat. Physical examination found: Compos Mentis (E4V5M6), BP:140/40 mmHg, HR : 92x/i, RR: 23x/i, T; 37.1°C, SpO2 : 95%. Chest examination showed vesicular breath sounds, Rhonki (-), Wheezing (-), Diastolic murmur (+).Echocardiography showed an EF of 70%. AR Severe, MR Moderate. AML Prolapse, Calcification (+), LV Dilatation, LVH Eccentric
风湿性心脏病(风湿性心脏病)是一种获得性心脏病,是一种由于既往急性风湿热而持续存在的心脏瓣膜疾病,主要影响二尖瓣(75%)、主动脉(25%),很少影响三尖瓣,从不影响瓣膜肺。52岁男性患者,居住在印度尼西亚Mutiara (value Awe) Lhokseumawe市。到卡特梅蒂亚医院综合门诊就诊。病人每月定期到综合诊所服药。病人主诉左胸痛、气短、心悸、咳嗽,活动时易疲劳,尤其是剧烈活动时。否认有糖尿病史,高血压史(+)。病人承认他在19岁时被诊断出患有风湿性心脏病。33年来,该患者每年定期进行心脏相关检查,每月定期在综合诊所接受药物治疗。病人承认在初中年龄,他经常出现发烧,上下起伏,并伴有喉咙疼痛。体检发现:Compos Mentis (E4V5M6),血压:140/40 mmHg, HR: 92x/i, RR: 23x/i, T;37.1℃,SpO2: 95%。胸部检查显示水泡性呼吸音,Rhonki (-), Wheezing(-),舒张杂音(+)。超声心动图显示EF为70%。AR严重,MR中度。AML脱垂,钙化(+),左室扩张,左室偏心
{"title":"A 52-Years Old Male Patient With Aorta Regurgitation Et Causa Rheumatic Heart Desease In Cut Meutia Regional General Hospital","authors":"Yuri Savitri, Jauza Raudhatul Jannah Mendrofa","doi":"10.14710/dmj.v11i6.35990","DOIUrl":"https://doi.org/10.14710/dmj.v11i6.35990","url":null,"abstract":"Rheumatic heart disease (rheumatic heart disease) is an acquired heart disease which is a heart valve disorder that persists due to previous acute rheumatic fever, mainly affecting the mitral valve (75%), the aorta (25%), rarely affecting the tricuspid valve, and never affecting the valves lungs. A 52-year-old male patient, domiciled in Mutiara (Alue Awe) Lhokseumawe City, Indonesia. Come for outpatient treatment at Polyclinic of Cut Meutia Hospital. Patients are who routinely go to the polyclinic every month to take medicine. The patient complains of left chest pain, shortness of breath, heart palpitations, cough, tired easily during activities, especially during strenuous activities. History of Diabetes Mellitus is denied, history of hypertension (+). The patient admitted that he was diagnosed with rheumatic heart disease at the age of 19 years. The patient has been undergoing treatment for 33 years by routinely complete checks related to his heart every year and regularly taking medication at the polyclinic every month. The patient admitted at junior high school age he often experienced attacks of fever that went up and down accompanied by pain in the throat. Physical examination found: Compos Mentis (E4V5M6), BP:140/40 mmHg, HR : 92x/i, RR: 23x/i, T; 37.1°C, SpO2 : 95%. Chest examination showed vesicular breath sounds, Rhonki (-), Wheezing (-), Diastolic murmur (+).Echocardiography showed an EF of 70%. AR Severe, MR Moderate. AML Prolapse, Calcification (+), LV Dilatation, LVH Eccentric","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132599752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Bibliometric Analysis of Nanocrystalline Cellulose Research as Medical Implant Using VOSviewer 利用VOSviewer对医用植入物纳米纤维素研究的文献计量学分析
Pub Date : 2022-11-01 DOI: 10.14710/dmj.v11i6.35896
Deaniar Hafilah, A. Nandiyanto
Background: Nanocrystalline cellulose has potential for biomedical applications due to its abundant material availability, biodegradability, biocompatibility, and low weight. Research on nanocrystalline cellulose as medical implants has rarely been studied in the past 10 years, although this material has tremendous potential such as bone implants and cardiovascular implants. Objective: This study aims to analyze the development of research on nanocrystalline cellulose as medical implants using a bibliometric approach with computational analysis using VOSviewer. Methods: The article data was obtained using the Publish or Perish software by retrieving the database from Google Scholar. The keyword “nanocrystalline cellulose, medical implants, biomedical" is used with the publication time span from 2012 to 2020. Data processing uses Microsoft Excel. Computational mapping using VOSviewer. Results: Research on the application of nanocrystalline cellulose has been carried out several times, this can be proven from computational mapping analysis using VOSviewer which shows the term "nanocrystalline cellulose" is in the same cluster as the term "medical implant". However, research on the application of nanocrystalline cellulose as medical implants is still rarely carried out, this is evidenced by the small frequency indicated by the two terms. Conclusion: Based on the results of mapping the collected article data, research on the application of nanocrystalline cellulose as medical implants is an interesting topic. However, this topic is still rarely studied. Therefore, this review can be a starting point for selecting the topic of research on the application of nanocrystalline cellulose materials as medical implants as a consideration for determining the research theme to be taken.
背景:纳米晶纤维素由于其丰富的材料可用性、生物可降解性、生物相容性和重量轻而具有潜在的生物医学应用。虽然纳米纤维素在骨植入、心血管植入等方面具有巨大的应用潜力,但其作为医用植入材料的研究在近10年来很少。目的:利用文献计量学方法,结合VOSviewer的计算分析,分析纳米纤维素作为医用植入物的研究进展。方法:通过检索Google Scholar数据库,使用Publish or Perish软件获取文章数据。关键词“纳米晶纤维素,医用植入物,生物医学”,发表时间跨度为2012 - 2020年。数据处理使用Microsoft Excel。使用VOSviewer计算映射。结果:关于纳米晶纤维素的应用研究已经进行了多次,这可以从VOSviewer的计算映射分析中得到证明,“纳米晶纤维素”一词与“医用植入物”一词处于同一簇。然而,纳米晶纤维素作为医疗植入物的应用研究仍然很少,这两个术语的出现频率很低。结论:基于收集到的文献数据的映射结果,纳米晶纤维素作为医疗植入物的应用研究是一个有趣的话题。然而,这一课题的研究仍然很少。因此,这篇综述可以作为选择纳米晶纤维素材料作为医疗植入物的研究课题的起点,作为确定研究主题的考虑因素。
{"title":"A Bibliometric Analysis of Nanocrystalline Cellulose Research as Medical Implant Using VOSviewer","authors":"Deaniar Hafilah, A. Nandiyanto","doi":"10.14710/dmj.v11i6.35896","DOIUrl":"https://doi.org/10.14710/dmj.v11i6.35896","url":null,"abstract":"Background: Nanocrystalline cellulose has potential for biomedical applications due to its abundant material availability, biodegradability, biocompatibility, and low weight. Research on nanocrystalline cellulose as medical implants has rarely been studied in the past 10 years, although this material has tremendous potential such as bone implants and cardiovascular implants. \u0000Objective: This study aims to analyze the development of research on nanocrystalline cellulose as medical implants using a bibliometric approach with computational analysis using VOSviewer. \u0000Methods: The article data was obtained using the Publish or Perish software by retrieving the database from Google Scholar. The keyword “nanocrystalline cellulose, medical implants, biomedical\" is used with the publication time span from 2012 to 2020. Data processing uses Microsoft Excel. Computational mapping using VOSviewer. \u0000Results: Research on the application of nanocrystalline cellulose has been carried out several times, this can be proven from computational mapping analysis using VOSviewer which shows the term \"nanocrystalline cellulose\" is in the same cluster as the term \"medical implant\". However, research on the application of nanocrystalline cellulose as medical implants is still rarely carried out, this is evidenced by the small frequency indicated by the two terms. \u0000Conclusion: Based on the results of mapping the collected article data, research on the application of nanocrystalline cellulose as medical implants is an interesting topic. However, this topic is still rarely studied. Therefore, this review can be a starting point for selecting the topic of research on the application of nanocrystalline cellulose materials as medical implants as a consideration for determining the research theme to be taken.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"65 2 Spec No 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126770230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A REVIEW OF THE MONKEYPOX OUTBREAK IN INDONESIA IN 2022 对2022年印度尼西亚猴痘疫情的回顾
Pub Date : 2022-09-30 DOI: 10.14710/dmj.v11i5.35895
Meiriani Sari, N. Hairunisa
Monkeypox disease (monkey smallpox) is a disease that has never been found in Indonesia since it was first discovered in humans in the Congo in 1970. So if there is one positive confirmed event, then the disease is an Extraordinary Event (KLB). This disease has become a global concern because since May 13, 2022, WHO has received reports of Monkeypox cases from non-endemic countries. It has expanded to 4 WHO regions: Europe, America, Eastern Mediterranean, and Western Pacific. Until now, further investigations and studies are still being carried out to understand more about the epidemiology, sources of infection, and transmission patterns in non-endemic countries that have reported new cases, such as Indonesia. Until now, no specific treatment has been proven to treat Monkeypox infection. Currently, the therapy used is symptomatic support. The antiviral tecovirimat, or TPOXX, developed by the European Medicines Agency (EMA) as a Monkeypox therapy in 2022 based on research, has not been marketed freely. In addition, antivirals such as cidofovir and brincidofovir have been shown to be effective against orthopox virus in vitro and in animal studies. However, the effectiveness of this drug against monkeypox in humans is not yet known. However, this disease can be prevented by vaccination. In Indonesia, the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is recommended to prevent Monkeypox disease. The existence of the outbreak report is important to discuss, explore, and understand more about the disease and its management and prevention.
猴痘病(猴天花)是一种自1970年在刚果首次在人类身上发现以来从未在印度尼西亚发现过的疾病。因此,如果有一个阳性确诊事件,那么这种疾病就是一个特别事件(KLB)。这种疾病已成为全球关注的问题,因为自2022年5月13日以来,世卫组织收到了来自非流行国家的猴痘病例报告。它已扩展到世卫组织4个区域:欧洲、美洲、东地中海和西太平洋。到目前为止,仍在进行进一步的调查和研究,以更多地了解已报告新病例的非流行国家(如印度尼西亚)的流行病学、感染源和传播模式。到目前为止,还没有特定的治疗方法被证明可以治疗猴痘感染。目前,使用的治疗方法是对症支持。抗病毒药物tecovirimat (TPOXX)是欧洲药品管理局(EMA)在2022年根据研究开发的猴痘治疗药物,目前尚未自由上市。此外,西多福韦和brincidofovir等抗病毒药物已在体外和动物研究中证明对正痘病毒有效。然而,这种药物对人类猴痘的有效性尚不清楚。然而,这种疾病可以通过接种疫苗来预防。在印度尼西亚,建议使用安卡拉-巴伐利亚北欧改良牛痘疫苗(MVA-BN)预防猴痘病。暴发报告的存在对于讨论、探索和更多地了解该疾病及其管理和预防具有重要意义。
{"title":"A REVIEW OF THE MONKEYPOX OUTBREAK IN INDONESIA IN 2022","authors":"Meiriani Sari, N. Hairunisa","doi":"10.14710/dmj.v11i5.35895","DOIUrl":"https://doi.org/10.14710/dmj.v11i5.35895","url":null,"abstract":"Monkeypox disease (monkey smallpox) is a disease that has never been found in Indonesia since it was first discovered in humans in the Congo in 1970. So if there is one positive confirmed event, then the disease is an Extraordinary Event (KLB). This disease has become a global concern because since May 13, 2022, WHO has received reports of Monkeypox cases from non-endemic countries. It has expanded to 4 WHO regions: Europe, America, Eastern Mediterranean, and Western Pacific. Until now, further investigations and studies are still being carried out to understand more about the epidemiology, sources of infection, and transmission patterns in non-endemic countries that have reported new cases, such as Indonesia. Until now, no specific treatment has been proven to treat Monkeypox infection. Currently, the therapy used is symptomatic support. The antiviral tecovirimat, or TPOXX, developed by the European Medicines Agency (EMA) as a Monkeypox therapy in 2022 based on research, has not been marketed freely. In addition, antivirals such as cidofovir and brincidofovir have been shown to be effective against orthopox virus in vitro and in animal studies. However, the effectiveness of this drug against monkeypox in humans is not yet known. However, this disease can be prevented by vaccination. In Indonesia, the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is recommended to prevent Monkeypox disease. The existence of the outbreak report is important to discuss, explore, and understand more about the disease and its management and prevention.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131051256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effect of Jump Rope Training on Mood Among Senior High School Students 跳绳训练对高中生情绪的影响
Pub Date : 2022-09-29 DOI: 10.14710/dmj.v11i5.35479
Nazilla Jufril, H. Hardian, Darmawati Ayu Indraswari, Endang Kumaidah
Background: Physical activity has protective effects against the development of depression symptoms for all age groups. Cognitive training and aerobic training are lifestyle interventions that have been shown to have a positive impact on health, reducing cognitive impairment, and delaying the onset of dementia. Jump rope training is one type of aerobic training. Aerobic training is effective in improving mood. Objective: This study aims to prove the effect of jump rope training on adolescent’s mood as measured by the POMS score. Methods: This is an experimental study with 2 parallel groups pre-test and post-test design. The research subjects were 32 students of senior-high school 1 of Gunung Talang, Solok Regency, West Sumatra that were selected by purposive sampling and grouped into 2 groups. The control group without treatment (n=16), and the treatment group (n=16) were given jump rope training for 6 weeks. Mood scores were measured before and after the intervention using a profile of mood state (POMS) questionnaire and expressed as total mood disturbance (TMD) scores. Results: The research shown the significant decreases of TMD scores (p<0.001) on the treatment group rather than the control group. In addition, there was a significant difference between the post-test TMD scores of the control group and the treatment group (p=0.005). Conclusion: Jump rope training for 6 weeks can improve the mood of the adolescent.Keywords: aerobic training, jump rope training, mood, profile of mood state, total mood disturbance
背景:体育活动对所有年龄组的抑郁症状的发展都有保护作用。认知训练和有氧训练是一种生活方式干预,已被证明对健康有积极影响,可以减少认知障碍,延缓痴呆症的发作。跳绳训练是有氧训练的一种。有氧训练对改善情绪很有效。目的:本研究旨在验证跳绳训练对青少年情绪的影响。方法:采用前测和后测两组平行设计的实验研究。研究对象为西苏门答腊省索洛克县古农达朗高中1年级32名学生,采用有目的抽样法,分为2组。对照组(n=16)和治疗组(n=16)给予6周的跳绳训练。使用情绪状态问卷(POMS)测量干预前后的情绪得分,并以总情绪障碍(TMD)得分表示。结果:治疗组TMD评分明显低于对照组(p<0.001)。另外,对照组与治疗组测试后TMD评分差异有统计学意义(p=0.005)。结论:6周的跳绳训练可以改善青少年的情绪。关键词:有氧训练,跳绳训练,情绪,情绪状态概况,总情绪障碍
{"title":"The Effect of Jump Rope Training on Mood Among Senior High School Students","authors":"Nazilla Jufril, H. Hardian, Darmawati Ayu Indraswari, Endang Kumaidah","doi":"10.14710/dmj.v11i5.35479","DOIUrl":"https://doi.org/10.14710/dmj.v11i5.35479","url":null,"abstract":"Background: Physical activity has protective effects against the development of depression symptoms for all age groups. Cognitive training and aerobic training are lifestyle interventions that have been shown to have a positive impact on health, reducing cognitive impairment, and delaying the onset of dementia. Jump rope training is one type of aerobic training. Aerobic training is effective in improving mood. Objective: This study aims to prove the effect of jump rope training on adolescent’s mood as measured by the POMS score. Methods: This is an experimental study with 2 parallel groups pre-test and post-test design. The research subjects were 32 students of senior-high school 1 of Gunung Talang, Solok Regency, West Sumatra that were selected by purposive sampling and grouped into 2 groups. The control group without treatment (n=16), and the treatment group (n=16) were given jump rope training for 6 weeks. Mood scores were measured before and after the intervention using a profile of mood state (POMS) questionnaire and expressed as total mood disturbance (TMD) scores. Results: The research shown the significant decreases of TMD scores (p<0.001) on the treatment group rather than the control group. In addition, there was a significant difference between the post-test TMD scores of the control group and the treatment group (p=0.005). Conclusion: Jump rope training for 6 weeks can improve the mood of the adolescent.Keywords: aerobic training, jump rope training, mood, profile of mood state, total mood disturbance","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132100630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baricitinib as Treatment Option for Corona Virus Disease-19: a Literature Review 巴西替尼作为冠状病毒病的治疗选择19:文献综述
Pub Date : 2022-09-14 DOI: 10.14710/dmj.v11i5.35628
T. Handoyo, Nurain Farhanah, Gianina Dinda Pamungkas
Background : Treatment of COVID-19 using IL-6 inhibitors, including Sarilumab or Tocilizumab, significantly decreased mortality risk. Though, Remdesivir therapy gave benefits, morbidity and mortality remained high. Baricitinib, a JAK inhibitor, can inhibit IL-6 activation pathway and has a potential effect of inhibiting disease progression to become severe. Objective : This study aimed to evaluate the use of Baricitinib for COVID-19 patients. Methods : This study was conducted by searching for observational and randomized controlled trial studies through online databases, “PubMed” and “Google Scholar”. Studies included must evaluate Baricitinib effectivity as therapy for hospitalized COVID-19 patients. This study included 11 studies (9 observational and 2 randomized controlled trial). Patients included had moderate-to-severe symptoms of COVID-19. Results : Standard dose of Baricitinib was administered at 4 mg daily dose. Length of therapy was varied between 5-14 days, or up to patients’ discharge. Baricitinib therapy among included studies was administered with intravenous Remdesivir, Steroid, Tocilizumab, or other complement therapies. Mortality rate within 7-day of hospitalization with Baricitinib was 4.4%. Requirement of invasive mechanic ventilation rate after Baricitinib administration was approximately 4%. Laboratory parameters were significantly getting better after Baricitinib administration: IL-6; CRP; ferritin; and D-dimer. Serious adverse events in a randomized controlled trial, occurred more often in placebo treated compared to Baricitinib treated group. Conclusion : Baricitinib as therapy for COVID-19 patients can decrease progression, morbidity, and mortality of the disease. Further studies are needed to evaluate the benefit of Baricitinib as main therapy for COVID-19.
背景:使用IL-6抑制剂(包括Sarilumab或Tocilizumab)治疗COVID-19可显著降低死亡风险。尽管瑞德西韦治疗有好处,但发病率和死亡率仍然很高。Baricitinib是一种JAK抑制剂,可以抑制IL-6激活途径,具有抑制疾病恶化的潜在作用。目的:评价Baricitinib在COVID-19患者中的应用。方法:本研究通过在线数据库“PubMed”和“谷歌Scholar”检索观察性和随机对照试验研究。纳入的研究必须评估Baricitinib作为治疗住院COVID-19患者的有效性。本研究共纳入11项研究(9项观察性试验和2项随机对照试验)。纳入的患者有中重度COVID-19症状。结果:Baricitinib标准剂量为4 mg / d。治疗时间在5-14天之间变化,或直到患者出院。在纳入的研究中,Baricitinib治疗与静脉注射Remdesivir、类固醇、Tocilizumab或其他补充疗法一起使用。巴西替尼住院7天内死亡率为4.4%。巴西替尼给药后有创机械通气率要求约为4%。巴西替尼给药后实验室参数明显改善:IL-6;c反应蛋白;铁蛋白;和肺动脉栓塞。在一项随机对照试验中,与Baricitinib治疗组相比,安慰剂治疗组的严重不良事件发生率更高。结论:Baricitinib治疗COVID-19患者可降低疾病进展、发病率和死亡率。需要进一步的研究来评估Baricitinib作为COVID-19主要治疗方法的益处。
{"title":"Baricitinib as Treatment Option for Corona Virus Disease-19: a Literature Review","authors":"T. Handoyo, Nurain Farhanah, Gianina Dinda Pamungkas","doi":"10.14710/dmj.v11i5.35628","DOIUrl":"https://doi.org/10.14710/dmj.v11i5.35628","url":null,"abstract":"Background : Treatment of COVID-19 using IL-6 inhibitors, including Sarilumab or Tocilizumab, significantly decreased mortality risk. Though, Remdesivir therapy gave benefits, morbidity and mortality remained high. Baricitinib, a JAK inhibitor, can inhibit IL-6 activation pathway and has a potential effect of inhibiting disease progression to become severe. \u0000Objective : This study aimed to evaluate the use of Baricitinib for COVID-19 patients. \u0000Methods : This study was conducted by searching for observational and randomized controlled trial studies through online databases, “PubMed” and “Google Scholar”. Studies included must evaluate Baricitinib effectivity as therapy for hospitalized COVID-19 patients. This study included 11 studies (9 observational and 2 randomized controlled trial). Patients included had moderate-to-severe symptoms of COVID-19. \u0000Results : Standard dose of Baricitinib was administered at 4 mg daily dose. Length of therapy was varied between 5-14 days, or up to patients’ discharge. Baricitinib therapy among included studies was administered with intravenous Remdesivir, Steroid, Tocilizumab, or other complement therapies. Mortality rate within 7-day of hospitalization with Baricitinib was 4.4%. Requirement of invasive mechanic ventilation rate after Baricitinib administration was approximately 4%. Laboratory parameters were significantly getting better after Baricitinib administration: IL-6; CRP; ferritin; and D-dimer. Serious adverse events in a randomized controlled trial, occurred more often in placebo treated compared to Baricitinib treated group. \u0000Conclusion : Baricitinib as therapy for COVID-19 patients can decrease progression, morbidity, and mortality of the disease. Further studies are needed to evaluate the benefit of Baricitinib as main therapy for COVID-19.","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129211522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMPARISON OF ANTIBACTERIAL EFFECTIVENESS OF HERBAL TOOTHPASTE AND FLUORIDE ON THE GROWTH OF Streptococcus mutans 中药牙膏与氟化物对变形链球菌生长的抑菌效果比较
Pub Date : 2022-09-14 DOI: 10.14710/dmj.v11i5.35640
Rosalia Indri Dewanti, V. R. Ciptaningtyas, Ryan Halleyantoro, Gustantyo Wahyu Wibobo
Background: Streptococcus mutans was the most dominant bacteria in caused caries. Caries could be prevented by chemical plaque control methods used toothpaste. Toothpaste had antibacterial properties by helped to prevent bacteria from colonized. There were two antibacterial ingredients in toothpaste, fluoride and herbal ingredients. Aim: Determined the antibacterial effect of toothpaste with herbal and fluoride content on the growth of Streptococcus mutans. Methods: This study was an experimental study with a post-test only control group design. This research method was a diffusion method by means of wells. The sample used was the Streptococcus mutans colony. The study was divided into four groups, namely herbal toothpaste, fluoride toothpaste, positive control (chlorhexidine), and negative control (aquadest sterile) which were replicated 16 times in each group. The results of this study was the diameter of the resistance zone. Results: The average diameter of the zone of inhibition results obtained 12.49 mm (herbal toothpaste), 14.66 mm (fluoride toothpaste), 21.70 mm (chlorhexidine) and aquadest sterile there were no inhibition zones. There was a significant difference with the p value
背景:变形链球菌是引起龋齿的最主要细菌。用牙膏控制牙菌斑的化学方法可以预防龋齿。牙膏具有抗菌特性,因为它有助于防止细菌的滋生。牙膏中有两种抗菌成分:氟化物和草药成分。目的:测定含氟牙膏和含草药牙膏对变形链球菌生长的抑菌作用。方法:本研究为实验研究,采用后验组设计。本研究方法为井扩散法。使用的样本是变形链球菌菌落。研究分为4组,分别为草药牙膏、含氟牙膏、阳性对照(氯己定)、阴性对照(aquadest无菌),每组重复16次。本研究的结果是阻力区的直径。结果:抑菌区平均直径为12.49 mm(中草药牙膏)、14.66 mm(氟牙膏)、21.70 mm(氯己定),无抑菌区。p值有显著性差异
{"title":"COMPARISON OF ANTIBACTERIAL EFFECTIVENESS OF HERBAL TOOTHPASTE AND FLUORIDE ON THE GROWTH OF Streptococcus mutans","authors":"Rosalia Indri Dewanti, V. R. Ciptaningtyas, Ryan Halleyantoro, Gustantyo Wahyu Wibobo","doi":"10.14710/dmj.v11i5.35640","DOIUrl":"https://doi.org/10.14710/dmj.v11i5.35640","url":null,"abstract":"Background: Streptococcus mutans was the most dominant bacteria in caused caries. Caries could be prevented by chemical plaque control methods used toothpaste. Toothpaste had antibacterial properties by helped to prevent bacteria from colonized. There were two antibacterial ingredients in toothpaste, fluoride and herbal ingredients. \u0000Aim: Determined the antibacterial effect of toothpaste with herbal and fluoride content on the growth of Streptococcus mutans. \u0000Methods: This study was an experimental study with a post-test only control group design. This research method was a diffusion method by means of wells. The sample used was the Streptococcus mutans colony. The study was divided into four groups, namely herbal toothpaste, fluoride toothpaste, positive control (chlorhexidine), and negative control (aquadest sterile) which were replicated 16 times in each group. The results of this study was the diameter of the resistance zone. \u0000Results: The average diameter of the zone of inhibition results obtained 12.49 mm (herbal toothpaste), 14.66 mm (fluoride toothpaste), 21.70 mm (chlorhexidine) and aquadest sterile there were no inhibition zones. There was a significant difference with the p value","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123464137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE EFFECTIVENESS OF KAFFIR LIME PEEL EXTRACT (Citrus hystrix) ON PLASMA MALONDIALDEHYDE LEVEL IN DEMENTIA MICE 青柠皮提取物对痴呆小鼠血浆丙二醛水平的影响
Pub Date : 2022-09-14 DOI: 10.14710/dmj.v11i5.35304
M. Ilham, Endang Mahati, M. Muniroh, Y. Nindita
ABSTRACTBackground: Antioxidant is a substance that can catch and neutralize free radicals so that the process of oxidative stress can be stopped and cell damage can be avoided. Kaffir lime peel contains antioxidant compounds that have the potential to be the neuroprotective agent and can protect neurons from free radical-induced damage.Objective: To evaluate the effect of kaffir lime peel extract (Citrus hystrix) on the plasma malondialdehyde (MDA) level of mice induced by Scopolamine (SCM).Method: This research was a true experimental study with a post-test-only controlled group design. Thirty mice were randomly divided into 5 groups consisting of a healthy control (K+), Negative Control (K-), extract 5 mg/20gBW group (P1), 10 mg/20gBW group (P2), 20 mg/20gBW group (P3). SCM was injected intraperitoneally on days 1-7 and kaffir lime peel extract was given orally on days 2-7, the MDA levels testing of mice using TBARS method on day 8. Data analysis used One-Way ANOVA test and continued with Post Hoc LSD test.Results: The mean MDA levels of K+, K-, P1, P2, P3 were 4,212; 4,644; 3,481; 4,555; 4,733 nmol/mL, respectively. MDA levels of P1 were lower than K-, even though there were no statistically significant differences.Conclusion: There was no effect of administration kaffir lime peel extract (Citrus hystrix) on MDA levels in mice with scopolamine-induced dementia.Keywords: Citrus hystrix, malondialdehyde, dementia, mice
摘要背景:抗氧化剂是一种能够捕获和中和自由基,从而阻止氧化应激过程,避免细胞损伤的物质。Kaffir酸橙皮含有抗氧化化合物,有可能成为神经保护剂,可以保护神经元免受自由基引起的损伤。目的:探讨青柠皮提取物对东莨菪碱(SCM)致小鼠血浆丙二醛(MDA)水平的影响。方法:本研究为真正意义上的实验研究,采用后验对照组设计。30只小鼠随机分为5组,分别为健康对照组(K+)、阴性对照组(K-)、提取物5 mg/20gBW组(P1)、10 mg/20gBW组(P2)、20 mg/20gBW组(P3)。第1-7天腹腔注射SCM,第2-7天口服kaffir青柠皮提取物,第8天采用TBARS法检测小鼠丙二醛水平。数据分析采用单因素方差分析,并继续采用Post Hoc LSD检验。结果:大鼠血清K+、K-、P1、P2、P3平均MDA水平为4212;4644;3481;4555;分别为4733 nmol/mL。P1的MDA水平低于K-,但差异无统计学意义。结论:枸杞皮提取物对东莨菪碱致痴呆小鼠MDA水平无影响。关键词:柑桔,丙二醛,痴呆,小鼠
{"title":"THE EFFECTIVENESS OF KAFFIR LIME PEEL EXTRACT (Citrus hystrix) ON PLASMA MALONDIALDEHYDE LEVEL IN DEMENTIA MICE","authors":"M. Ilham, Endang Mahati, M. Muniroh, Y. Nindita","doi":"10.14710/dmj.v11i5.35304","DOIUrl":"https://doi.org/10.14710/dmj.v11i5.35304","url":null,"abstract":"ABSTRACTBackground: Antioxidant is a substance that can catch and neutralize free radicals so that the process of oxidative stress can be stopped and cell damage can be avoided. Kaffir lime peel contains antioxidant compounds that have the potential to be the neuroprotective agent and can protect neurons from free radical-induced damage.Objective: To evaluate the effect of kaffir lime peel extract (Citrus hystrix) on the plasma malondialdehyde (MDA) level of mice induced by Scopolamine (SCM).Method: This research was a true experimental study with a post-test-only controlled group design. Thirty mice were randomly divided into 5 groups consisting of a healthy control (K+), Negative Control (K-), extract 5 mg/20gBW group (P1), 10 mg/20gBW group (P2), 20 mg/20gBW group (P3). SCM was injected intraperitoneally on days 1-7 and kaffir lime peel extract was given orally on days 2-7, the MDA levels testing of mice using TBARS method on day 8. Data analysis used One-Way ANOVA test and continued with Post Hoc LSD test.Results: The mean MDA levels of K+, K-, P1, P2, P3 were 4,212; 4,644; 3,481; 4,555; 4,733 nmol/mL, respectively. MDA levels of P1 were lower than K-, even though there were no statistically significant differences.Conclusion: There was no effect of administration kaffir lime peel extract (Citrus hystrix) on MDA levels in mice with scopolamine-induced dementia.Keywords: Citrus hystrix, malondialdehyde, dementia, mice","PeriodicalId":394284,"journal":{"name":"DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)","volume":"112 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122824862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1